WELLS FARGO & COMPANY/MN - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 161 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$131,848
-24.7%
31,244
-44.7%
0.00%
Q2 2023$175,169
+470.5%
56,506
+155.8%
0.00%
Q1 2023$30,706
+1174.1%
22,090
+1724.1%
0.00%
Q4 2022$2,410
-91.4%
1,211
-91.3%
0.00%
Q3 2022$28,000
-41.7%
13,862
-7.5%
0.00%
Q2 2022$48,000
-95.1%
14,984
-93.7%
0.00%
Q1 2022$988,000
-46.8%
236,802
-39.0%
0.00%
Q4 2021$1,858,000
-53.9%
387,903
-48.6%
0.00%
-100.0%
Q3 2021$4,030,000
-10.0%
754,691
-13.7%
0.00%0.0%
Q2 2021$4,478,000
-20.2%
874,604
+4.9%
0.00%0.0%
Q1 2021$5,610,000
+265.0%
833,782
+147.8%
0.00%
Q4 2020$1,537,000
+6.4%
336,431
-9.6%
0.00%
Q3 2020$1,445,000
-1.7%
372,123
+20.4%
0.00%
Q2 2020$1,470,000
+97.1%
308,999
+44.2%
0.00%
Q1 2020$746,000
-74.2%
214,326
-64.3%
0.00%
-100.0%
Q4 2019$2,895,000
+8.3%
600,885
-34.8%
0.00%0.0%
Q3 2019$2,674,000
+99.1%
921,905
+392.1%
0.00%
Q2 2019$1,343,000
-74.4%
187,356
-49.5%
0.00%
-100.0%
Q1 2019$5,253,000
+18.9%
370,669
+13.5%
0.00%
+100.0%
Q4 2018$4,417,000
-33.7%
326,515
+8.7%
0.00%
-50.0%
Q3 2018$6,665,000
+41.4%
300,348
+4.5%
0.00%
+100.0%
Q2 2018$4,715,000287,3110.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$83,503,0007.34%
Eversept Partners, LP 2,656,208$10,306,0872.29%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$62,908,0001.13%
Prosight Management, LP 512,659$1,989,0000.95%
THB ASSET MANAGEMENT 833,104$3,232,0000.90%
GLOBEFLEX CAPITAL L P 251,696$977,0000.26%
XTX MARKETS LLC 10,243$40,0000.19%
HUSSMAN STRATEGIC ADVISORS, INC. 102,000$396,0000.10%
PA Capital LLC 33,874$132,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 60,900$236,0000.07%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders